Healthcare provider profile · identity verified

Aileen Andreu, MD

Internal Medicine · MIAMI, FL · NPI 1063647014

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	540	164
Atorvastatin Calcium	Atorvastatin Calcium	450	149
Losartan Potassium	Losartan Potassium	337	105
Metformin Hcl	Metformin Hcl	323	99
Levothyroxine Sodium	Levothyroxine Sodium	316	82
Amlodipine Besylate	Amlodipine Besylate	300	94
Fluticasone Propionate	Fluticasone Propionate	290	95
Lisinopril	Lisinopril	281	78
Omeprazole	Omeprazole	271	91
Metoprolol Succinate	Metoprolol Succinate	224	72
Hydrochlorothiazide	Hydrochlorothiazide	215	68
Famotidine	Famotidine	209	72
Albuterol Sulfate Hfa	Albuterol Sulfate	196	74
Trazodone Hcl	Trazodone Hcl	190	49
Gabapentin	Gabapentin	176	61
Alendronate Sodium	Alendronate Sodium	167	50
Pantoprazole Sodium	Pantoprazole Sodium	135	42
Eliquis	Apixaban	131	34
Ketoconazole	Ketoconazole	129	42
Ozempic	Semaglutide	127	22
Metoprolol Tartrate	Metoprolol Tartrate	126	37
Azelastine Hcl	Azelastine Hcl	125	29
Montelukast Sodium	Montelukast Sodium	121	36
Escitalopram Oxalate	Escitalopram Oxalate	119	34
Glipizide	Glipizide	115	29
Tamsulosin Hcl	Tamsulosin Hcl	114	42
Mounjaro	Tirzepatide	111	21
Alprazolam	Alprazolam	104	23
Vitamin D2	Ergocalciferol (Vitamin D2)	102	66
Diclofenac Sodium	Diclofenac Sodium	95	43
Linzess	Linaclotide	95	25
Donepezil Hcl	Donepezil Hcl	94	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	92	25
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	88	40
Ibuprofen	Ibuprofen	87	57
Sertraline Hcl	Sertraline Hcl	83	24
Mirtazapine	Mirtazapine	81	31
Jardiance	Empagliflozin	79	20
Meclizine Hcl	Meclizine Hcl	76	21
Januvia	Sitagliptin Phosphate	75	18
Allopurinol	Allopurinol	74	28
Tadalafil	Tadalafil	68	suppressed
Furosemide	Furosemide	67	19
Atenolol	Atenolol	63	21
Hydrocortisone	Hydrocortisone	61	43
Temazepam	Temazepam	61	suppressed
Carvedilol	Carvedilol	60	18
Ezetimibe	Ezetimibe	60	24
Spironolactone	Spironolactone	60	13
Nifedipine Er	Nifedipine	58	15
Duloxetine Hcl	Duloxetine Hcl	56	suppressed
Finasteride	Finasteride	56	17
Baclofen	Baclofen	53	39
Simvastatin	Simvastatin	53	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	suppressed
Clonazepam	Clonazepam	52	13
Tradjenta	Linagliptin	52	12
Xarelto	Rivaroxaban	52	14
Azithromycin	Azithromycin	47	32
Clopidogrel	Clopidogrel Bisulfate	46	15
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	45	15
Ammonium Lactate	Ammonium Lactate	44	17
Dicyclomine Hcl	Dicyclomine Hcl	42	suppressed
Gemtesa	Vibegron	42	18
Memantine Hcl	Memantine Hcl	42	16
Ciclopirox	Ciclopirox	41	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Folic Acid	Folic Acid	40	14
Glimepiride	Glimepiride	40	14
Latanoprost	Latanoprost	40	suppressed
Meloxicam	Meloxicam	38	17
Mupirocin	Mupirocin	38	29
Carbidopa-Levodopa	Carbidopa/Levodopa	37	suppressed
Naproxen	Naproxen	36	22
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Myrbetriq	Mirabegron	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	15
Alcohol Swabs	Alcohol Antiseptic Pads	34	suppressed
Valsartan	Valsartan	33	13
Entresto	Sacubitril/Valsartan	32	suppressed
Farxiga	Dapagliflozin Propanediol	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Vascepa	Icosapent Ethyl	32	13
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Sildenafil Citrate	Sildenafil Citrate	29	suppressed
Methylprednisolone	Methylprednisolone	27	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	20
Hydralazine Hcl	Hydralazine Hcl	26	12
Olmesartan Medoxomil	Olmesartan Medoxomil	26	12
Glipizide Er	Glipizide	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Restasis	Cyclosporine	24	suppressed
Solifenacin Succinate	Solifenacin Succinate	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Insulin Aspart Flexpen	Insulin Aspart	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	17
Chlorthalidone	Chlorthalidone	19	suppressed
Cholestyramine	Cholestyramine (With Sugar)	19	suppressed
Cilostazol	Cilostazol	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Methocarbamol	Methocarbamol	17	12
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Ciclopirox	Ciclopirox Olamine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	14	suppressed
Lactulose	Lactulose	14	suppressed
Methimazole	Methimazole	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Benzonatate	Benzonatate	13	suppressed
Erythromycin	Erythromycin Base	13	13
Fluocinonide	Fluocinonide	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Procto-Med Hc	Hydrocortisone	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Amoxicillin	Amoxicillin	12	11
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Cholestyramine Light	Cholestyramine	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Letrozole	Letrozole	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	11
Prolia	Denosumab	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Veltassa	Patiromer Calcium Sorbitex	12	suppressed
Acetic Acid	Acetic Acid	11	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Insulin Aspart	Insulin Aspart	11	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	11	suppressed
Nystatin	Nystatin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Primidone	Primidone	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error